Singapore markets closed

Straits Times Index
3,297.55
-26.98(-0.81%)
Nikkei
38,102.44
-712.12(-1.83%)
Hang Seng
17,936.12
-5.66(-0.03%)
FTSE 100
8,147.26
+0.40(+0.00%)
Bitcoin USD
65,612.49
-938.35(-1.41%)
CMC Crypto 200
1,368.47
-19.69(-1.42%)

HRMY Jul 2024 35.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

5.65

0.00

(0.00%)

As of 10:56AM EDT. Market open.

PR Newswire
HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1
Harmony Biosciences (Nasdaq: HRMY) presented data from its Phase 2 signal detection study showing that pitolisant reduced excessive daytime sleepiness (EDS) and fatigue in adults with Myotonic dystrophy Type 1 (DM1).
PR Newswire
HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, FL on Monday, June 10, 2024, at 9:20 a.m. ET.
Simply Wall St.
Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Investors in Harmony Biosciences Holdings, Inc. ( NASDAQ:HRMY ) had a good week, as its shares rose 7.7% to close at...